BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20817506)

  • 21. Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.
    Gusscott S; Kuchenbauer F; Humphries RK; Weng AP
    Leuk Res; 2012 Jul; 36(7):905-11. PubMed ID: 22424712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
    Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
    Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.
    Kumar V; Palermo R; Talora C; Campese AF; Checquolo S; Bellavia D; Tottone L; Testa G; Miele E; Indraccolo S; Amadori A; Ferretti E; Gulino A; Vacca A; Screpanti I
    Leukemia; 2014 Dec; 28(12):2324-35. PubMed ID: 24727676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on Notch signaling in human breast cancer.
    Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
    Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
    Lee SH; Jeong EG; Yoo NJ; Lee SH
    APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells.
    Yonekura S; Itoh M; Okuhashi Y; Takahashi Y; Ono A; Nara N; Tohda S
    Anticancer Res; 2013 Aug; 33(8):3099-103. PubMed ID: 23898065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
    Giovannini C; Gramantieri L; Chieco P; Minguzzi M; Lago F; Pianetti S; Ramazzotti E; Marcu KB; Bolondi L
    J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.
    Mezquita B; Mezquita J; Barrot C; Carvajal S; Pau M; Mezquita P; Mezquita C
    J Cell Biochem; 2014 Jan; 115(1):52-61. PubMed ID: 23904188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
    Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
    Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.
    Hannon MM; Lohan F; Erbilgin Y; Sayitoglu M; O'Hagan K; Mills K; Ozbek U; Keeshan K
    Br J Haematol; 2012 Sep; 158(5):626-34. PubMed ID: 22775572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch3 activation is sufficient but not required for inducing human T-lineage specification.
    Waegemans E; Van de Walle I; De Medts J; De Smedt M; Kerre T; Vandekerckhove B; Leclercq G; Wang T; Plum J; Taghon T
    J Immunol; 2014 Dec; 193(12):5997-6004. PubMed ID: 25381438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
    Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
    Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration.
    Bhavsar PJ; Infante E; Khwaja A; Ridley AJ
    Oncogene; 2013 Jan; 32(2):198-208. PubMed ID: 22349824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
    Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
    Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
    Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.